Booster shots for the coronavirus vaccine will be needed at some point, but it’s too early to say how often they will be needed, Moderna CEO Stephane Bancel told “Maria Bartiromo’s Wall Street” in a report. exclusive interview.
“The variant is going to be the big question in terms of boosting,” Bancel explained to host Maria Bartiromo. “One thing to think about is natural immunity. When you are infected, you make antibodies or [when] we get vaccinated and we make antibodies, over time the antibody level will drop, it’s normal and natural. Over time increases will be needed, it is too early to know how often as we do not have enough data. “
Bartiromo questioned whether the variants should be considered “disturbing”.
“We don’t know how the variants will impact long-term efficiency,” Bancel said. “In the short term, we are not worried. The B 1.1.7, the [variant] identified in the UK, which is currently important in the US, we have seen and published that the antibody level is similar to an older strain of the virus. We feel very good with this one. “
MODERNA COVID-19 VACCINE LASTS AT LEAST SIX MONTHS, STUDY FINDS
Bancel pointed out that Moderna’s two-dose vaccine is “north of 90% effective” and “appears to be doing very well in the real world.”
“We are very confident about a vaccine and continue to advise people [that], given the risk of lung disease, it is important to bring the pandemic under control so that we can resume our normal lives and be with loved ones. “
Regarding the US decision to suspend the distribution of the Johnson & Johnson vaccine due to the reporting of blood clots in a small number of recipients, Bancel said he has been monitoring vaccine safety “very carefully” since the injections of his company received emergency authorization from the Food. and Drug Administration (FDA) in December.
CLICK HERE TO GET THE FOX NEWS APP
“I think the good news, if there is a silver lining, is that Americans feel good about the CDC and the FDA, and how they take the safety of American citizens very seriously.” , did he declare. “I believe and trust the FDA, CDC, and scientists and advisers to do the right thing for the American people.”
The CEO also stressed that the recalls “are going to be really important in keeping the country safe and open and we are working very hard. In thirty days, Moderna has developed a variant of the boost for the South African strain. We have released data this week showing it. works very well in animals, we will have human data very soon. “